Topic: bankruptcy

Boston Harbor

Bankrupt biotech Bind eyes $20M sale to Pfizer

The Robert Langer-backed nanoparticle cancer biotech Bind, after a decade in the business, looks to be at the end of the road after the company said it was seeking an approval for a “stalking horse” bid today from Pfizer.